Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics

UU Malik, S Zarina, SR Pennington - Archives of oral biology, 2016 - Elsevier
Background The molecular and cellular mechanisms underlying the pathogenesis of oral
squamous cell carcinoma (OSCC) are relatively poorly understood and remain a subject of …

Label-free mass spectrometry-based protein quantification technologies in proteomic analysis

M Wang, J You, KG Bemis, TJ Tegeler… - Briefings in functional …, 2008 - academic.oup.com
Major technological advances have made proteomics an extremely active field for biomarker
discovery and validation in recent years. These improvements have lead to an increased …

Targeting SOD1 via RNAi with PEGylated graphene oxide nanoparticles in platinum-resistant ovarian cancer

A Szénási, E Sivasudhan, H Du, P Zhang… - Cancer Gene …, 2023 - nature.com
Acquired platinum resistance poses a significant therapeutic impediment to ovarian cancer
patient care, accounting for more than 200,000 deaths annually worldwide. We previously …

Proteomic analysis of blastema formation in regenerating axolotl limbs

N Rao, D Jhamb, DJ Milner, B Li, F Song, M Wang… - BMC biology, 2009 - Springer
Background Following amputation, urodele salamander limbs reprogram somatic cells to
form a blastema that self-organizes into the missing limb parts to restore the structure and …

Proteomics analysis of ovarian cancer cell lines and tissues reveals drug resistance-associated proteins

IN Cruz, HM Coley, HB Kramer… - Cancer genomics & …, 2017 - cgp.iiarjournals.org
Background: Carboplatin and paclitaxel form the cornerstone of chemotherapy for epithelial
ovarian cancer, however, drug resistance to these agents continues to present challenges …

Anticancer metallodrug research analytically painting the “omics” picture—current developments and future trends

M Groessl, CG Hartinger - Analytical and bioanalytical chemistry, 2013 - Springer
Anticancer metallodrug development has for a long time been characterised by the similarity
of new drug candidates to cisplatin and DNA as the primary target. Recent advances in …

N-Glycome changes reflecting resistance to platinum-based chemotherapy in ovarian cancer

M Zahradnikova, I Ihnatova, E Lattova, L Uhrik… - Journal of …, 2021 - Elsevier
A number of studies have reported aberrant glycosylation in connection with malignancy.
Our investigation further expands on this topic through the examination of N-glycans, which …

LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis

SK Huang, MM Darfler, MB Nicholl, J You, KG Bemis… - PLoS …, 2009 - journals.plos.org
Background Melanoma metastasis status is highly associated with the overall survival of
patients; yet, little is known about proteomic changes during melanoma tumor progression …

Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer

DPG Brown, H Chin-Sinex, B Nie… - Cancer chemotherapy …, 2009 - Springer
Purpose Clinical drug resistance to platinum-based chemotherapy is considered a major
impediment in the treatment of human ovarian cancer. Multiple pathways associated with …

Proteomic analysis of fibroblastema formation in regenerating hind limbs of Xenopus laevis froglets and comparison to axolotl

N Rao, F Song, D Jhamb, M Wang, DJ Milner… - BMC developmental …, 2014 - Springer
Background To gain insight into what differences might restrict the capacity for limb
regeneration in Xenopus froglets, we used High Performance Liquid Chromatography …